Cristina Larkin
2020
In 2020, Cristina Larkin earned a total compensation of $992K as Former Chief Operating Officer at Spero Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $225,968 |
|---|---|
| Option Awards | $352,600 |
| Salary | $404,052 |
| Other | $9,342 |
| Total | $991,962 |
Larkin received $404.1K in salary, accounting for 41% of the total pay in 2020.
Larkin also received $226K in non-equity incentive plan, $352.6K in option awards and $9.3K in other compensation.
Rankings
In 2020, Cristina Larkin's compensation ranked 8,688th out of 13,090 executives tracked by ExecPay. In other words, Larkin earned more than 33.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,688 out of 13,090 | 34th |
Division Manufacturing | 3,703 out of 5,620 | 34th |
Major group Chemicals And Allied Products | 1,496 out of 2,253 | 34th |
Industry group Drugs | 1,303 out of 1,953 | 33rd |
Industry Pharmaceutical Preparations | 962 out of 1,458 | 34th |
Source: SEC filing on August 5, 2022.
Larkin's colleagues
We found one more compensation record of an executive who worked with Cristina Larkin at Spero Therapeutics in 2020.
2020
Ankit Mahadevia
Spero Therapeutics